Other

West Pharmaceutical Services·Balance Sheet Statement·38 metrics

Breakdown

Loading...

Metrics

Cumulative Cost Basis

Business Combination, Contingent Consideration, Liability

Common stock, par value (in dollars per share)

Common stock, shares authorized (in shares)

Common stock, shares issued (in shares)

Common Stock, Shares, Outstanding

Contract with Customer, Asset, after Allowance for Credit Loss

Contract with Customer, Liability

Long-term debt, gross

Debt Instrument, Fair Value Disclosure

Deferred Compensation Liability, Classified, Noncurrent

Deferred compensation plan assets

Deferred income taxes

Current maturities of long-term debt

Finance Lease Liability Payments Due

2027

Finance Lease Liability Payments Due Year Four

Finance Lease Liability Payments Due Year Three

Finance Lease Liability Payments Due Year Two

Thereafter

Finance Lease Liability Undiscounted Excess Amount

Finance Lease, Right-of-Use Asset, after Accumulated Amortization

Lessee Operating Lease Liability Payments Due

Thereafter

Lessee Operating Lease Liability Undiscounted Excess Amount

Operating Lease Weighted Average Discount Rate Percent

Deferred compensation liabilities

Preferred Stock, Shares Authorized

Preferred Stock, Shares Issued

Preferred Stock, Shares Outstanding

Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied

Incentive stock program, shares reserved for future grants (in shares)

Treasury stock, shares (in shares)

Unamortized Debt Issuance Expense

Unrecognized tax benefits

Remainder of Fiscal Year 2024

Weighted-Average Discount Rate

Weighted-Average Discount Rate - Finance Leases